News | ACC | March 21, 2018

ACC 2018 Late-Breaking Trials

Latest clinical data in cardiology will be presented at the 2018 American College of Cardiology meeting

ACC 2018 Late-Breaking Trials Announced

Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presented at ACC18, March 10-12 in Orlando, Fla. The studies are linked to articles specific to the trial presentations.

Preview some of the hot topics at at ACC 2018 with the editor's of the ACC journals in the article "What Trends are Ahead in Cardiovascular Medicine in 2018?"
 

 

Joint American College of Cardiology/Journal of American College of Cardiology Late-Breaking Clinical Trials
Saturday, March 10

Featured Clinical Research I
Saturday, March 10

Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials
Sunday, March 11

Late-Breaking Clinical Trials
Sunday, March 11

Featured Interventional Clinical Research II
Sunday, March 11

Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials
Monday, March 12

Late-Breaking Clinical Trials: Interventional Cardiology
Monday, March 12

Featured Interventional Clinical Research III
Monday, March 12

Other Featured Research:

CoreValve TAVR System Shows Strong Long-Term Performance in Clinical Trials

Aspirin Lowers Risk of Death for Patients with Diabetes, Heart Failure

ECG on Smartwatch Accurately Detects AFib

Getting Flu Vaccine Cuts Risk of Death by Half in People with Heart Failure

Breastfeeding May Have Long-Term Heart Health Benefits for Some Moms

Marked Increase in Cardiovascular Risk Factors in Women After Preeclampsia

 

ACC.18 Video Interviews:

VIDEO: Editor's Choice of Most Innovative New Cardiac Technology at ACC 2018

VIDEO: Sex Differences in Diagnosing Heart Disease in Women — interview with Doreen DeFaria Yeh, M.D.

VIDEO: TAVR for Degenerated Surgical Valves — Valve-in-Valve TAVR Procedures — interview with Sammy Elmariah, M.D.

VIDEO: iFR Found More Cost Effective Over Standard FFR — interview with  Manesh Patel, M.D.

VIDEO: Addressing Adult Congenital Heart Referrals — discussion with Ami Bhatt, M.D.

VIDEO: How to Avoid Acute Kidney Injury in the Cath Lab —  discussion with Hitinder Gurm, M.D.

VIDEO: Therapies for Advanced Heart Failure — interview with David Lanfear M.D.

VIDEO: Detection of Vulnerable Plaque and Pre-emptive Stenting — discussion with Ron Waksman, M.D.

VIDEO: Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast — interview with Roxana Mehran, M.D.

 

 

 

 

Vendor Product News at ACC.18:

Siemens Healthineers Launches Next Generation of syngo Dynamics at ACC 2018

Infraredx Highlights Value of IVUS + NIRS for Detecting Lipid Core Plaque at ACC.18

CorFlow Presents New Insights Into Coronary Microcirculation at ACC

Siemens Healthineers Introduces Portable Cardiovascular-Dedicated Ultrasound at ACC.18

 

 

RELATED CONTENT

ACC 2017 Late-Breaking Trials

AHA 2017 Late-breaking Trials

Late-breaking Trial Presentations at ESC 2017

Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials

Late-Breaking Clinical Trial Presentations at SCAI 2017

TCT 2017 Late-breaking Clinical Trial Presentations

VIVA 2017 Late-breaking Clinical Trial Presentations

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Ticagrelor Has Comparable Safety to Clopidogrel after Heart Attack

Image from presentation, "Ticagrelor Versus Clopidogrel After Thrombolytic Therapy in Patients With St-Elevation Myocardial Infarction: A Randomized Clinical Trial," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the m
Overlay Init